The present studies are concerned with the parameters which control the appearance of locally synthesized or serum-derived antibodies in the intestine. The data show that intestinal antibody may be found in rabbits as well as in conventional or germfree mice after active immunization with Vibrio cholerae. However, a large fraction of the intestinal antibody in rabbits and conventional mice originated from the serum as indicated by (i) analysis of correlation between serum and intestinal antibody titers, and (ii) the occurrence of intestinal antibody after parenteral administration of antiserum. In contrast, only locally synthesized 1i1S immunoglobulin A antibody was detected in the intestine of actively immunized germfree mice. No intestinal antibody was demonstrable in germfree mice after parenteral injection of V. cholerae antiserum. With respect to the appearance of serum antibody in the intestine, the response of conventionalized (ex-germfree) mice was intermediate between that of rabbits or conventional mice and germfree mice. The availability of serum-derived coproantibody in germfree and conventional mice was related to the rates of intestinal degradation of serum antibody. When enzymes were removed by prior washing of intestinal segments, serum antibodies entered the intestine of germfree or conventional mice at similar rates. Rates of entry of serum antibodies into the lumen were comparable at different levels of the small intestine. The presence of a normal enteric flora appeared to protect intestinal antibody from degradation by lowering the concentration or activity of intestinal enzymes. The results are discussed in relation to the question of whether antibacterial immunity to cholera involves local or systemic mechanisms.
Experimental cholera may be induced in a variety of animals. In all of these the bacteria remain confined to the lumen of the intestinal tract, as is the case in the natural disease. Experimental cholera is therefore an excellent model for the study of local immune mechanisms in the intestine, and a good amount of literature has been published on the subject. Unfortunately, the data available in the literature pertaining to the mechanism of immunity in experimental and natural cholera are difflcult to interpret. The work of some investigators suggests that resistance to cholera could be explained on the basis of immune mechanisms operating locally in the gastrointestinal tract, as opposed to systemically (8, 9, 17, 33) . In contrast to this, other published re- sults indicate that resistance to natural and experimental cholera may be explained on the basis of systemic (rather than local) immunity. The latter view may be based on findings of elevated specific antibody titers in human sera after cholera (50) ; on an inverse relationship between serum antibody titers and likelihood of developing cholera (1, 3, (41) (42) (43) (44) 46) ; and, most frequently, on protection of experimental animals from manifestations of disease, by passive administration of hyperimmune antisera. The passive immunization experiments (12, 24, 29, 39, 47) differ from one study to the next in terms of the type of antibody used for protection (i.e., antibacterial versus antitoxic), the minimal effective titers of such antibodies, and the parameters on which the determination of protection was based. Reviewing the above and other passive transfer experiments, Tomasi and Bienenstock (51) concluded that these "are confusing; some apparently show passage of antibody into the bowel lumen while others fail to demonstrate significant protection from parenterally administered antibody."
The need for better understanding is also apparent from a recent discussion of a paper by Pierce (56) .
In discussing various possible reasons for the above state of affairs, the reviewers (51) suggested that the different types of immunity in cholera may be a factor contributing to seemingly divergent FUBARA AND FRETER results in the literature. Indeed, evidence is available indicating that protection against cholera may be antitoxic (13, 31, 49) , antibacterial (7, 23, 29, 39, 41, 43) , or associated with reduced adsorption of vibrios to the intestinal mucosa (17, 20, 21) . It is obvious that this diversity of types of immunity complicates an analysis of the relative contributions of local and systemic factors to resistance to cholera. However, this is by no means the only complicating factor. For example, Curlin and Carpenter (12) recently concluded that "it seems likely, therefore, that antitoxic antibodies must be present in the gut lumen in order to block the effect of cholera enterotoxin." In contrast, Burrows (7) concluded from his studies that "the significant element in the [antitoxic] immunity was a function of tissue-contained antibody as reflected in serum antibody titer," whereas "neutralizing antibody in washings of the lower ileum, and representing secretory antibody, was unrelated to immunity ... ." Thus, two laboratories working with the same vibrio antigen (the enterotoxin) have recently (in 1971) come to conclusions which appear to be entirely reasonable within the context of the evidence considered by the authors. Nevertheless, when placed in juxtaposition they still leave the reader with the same degree of confusion experienced by Tomasi and Bienenstock 3 years earlier (51) .
It appears from the above discussion that one cannot conclude, from the data available in the literature, which of the two mechanisms of immunity (i.e., systemic or local immunity) may be operative in resistance against experimental cholera. It is the opinion of the present authors that this lack of understanding may, at least in part, be attributed to the failure of some investigators to delineate experimentally the various parameters which contribute to the phenomenon of local immunity. Indeed, this lack of detailed analysis is reflected in the various interpretations which different writers have applied to the term "local immunity." Thus, this term has been used to describe reactions involving secretory immunoglobulin A (IgA), as contrasted with other immunoglobulins. In other instances, the term "local immunity" has been used to indicate that the critical interaction between host and pathogen occurs locally (e.g., in the intestinal lumen), without regard to the mode by which active reactants such as antibodies are delivered to this site.
All investigators agree that antibodies (antitoxic, or antibacterial, or both) are responsible for protection in experimental cholera. Consequently, the crucial parameters which must be delineated before the understanding of immunity to enteric infections can progress beyond the present level are: (i) Is it necessary for antibodies to enter the lumen of the gut, or are systemic (circulating or tissue) antibodies sufficient to confer effective immunity? (ii) If antibodies must be present locally, what parameters determine their availability at this site? Is it possible for systemic antibody to diffuse into the lumen of the intestine in appreciable quantities, or is it necessary that antibody be locally synthesized in order to be present in the lumen of the intestine in protective concentrations?
The studies reported herein are concerned with the latter question. It appeared necessary to study this problem first, because much of the published evidence pertaining to question (i) is based on experiments testing for protection after passive intravenous immunization of experimental animals. The interpretation of such data is impossible as long as it is not known whether, and to what extent, such antibody may appear in the intestinal lumen. The studies reported in the present paper were therefore undertaken to determine the conditions under which antibody in the intestine might originate from local synthesis or from systemic sources. Preliminary to these studies, antibody assay methods were evaluated for their relative sensitivity in detecting antibody in different immunoglobulin classes. This paper is taken from a thesis submitted by Ernest S. Fubara to the Horace H. Rackham School of Graduate Studies at the University of Michigan, in partial fulfillment of the requirements for the degree of Doctor of Philosophy. Microfilm copies of the dissertation are available for study at the Library of Congress and the University of Michigan Library.
SOURCES OF INTESTINAL ANTIBODIES
antibody on the day of collection or were stored at -20 C.
Mice were anesthetized with chloroform and then bled to death by severing the subclavian artery. Blood was withdrawn from the "axillary pocket" with Pasteur pipettes.
The small intestine from each mouse was excised, and the serosal surface was rinsed in chilled saline. The lumen was then washed with 10 ml of chilled saline. Each wash was homogenized in a Branson sonifer, at 8 A for 10 sec, and clarified by centrifugation followed by filtration through Whatman no. 1 ifiter paper. The supematant fluid was precipitated with an equal volume of saturated ammonium sulfate at room temperature and resuspended to a fraction of the starting volume. Antibody titers in intestinal washings were calculated on the basis that the total volume of fluid in each intestine was 1 ml.
Antibody assay methods: Farr test of antigen-binding capacity. A soluble antigen from a streptomycinresistant strain of Vibrio cholerae (Ogawa) was used. The procedure used has been described earlier (19) .
Bactericidal test. A modification of the procedure described by Finkelstein (16) was followed. Details of the modified procedure have been reported (Fubara, Ph.D. thesis). Pooled guinea pig serum, which had been absorbed in the cold with boiled vibrios (34, 40) was used as the source of complement. As little as 0.6 mg (dry weight) of vibrios per ml of guinea pig serum was effective in removing natural antibodies to V. cholerae, while complement activity remained unimpaired. Each batch of absorbed guinea pig serum was titrated in the bactericidal test with a limiting concentration of the standard V. cholerae antiserum, to determine the concentration of guinea pig serum required in the test. In most instances, the absorbed guinea pig serum was added to a final concentration of 2.5% (v/v). However, since intestinal scrapings and washings were shown to be anticomplementary (Fubara, Ph. D. thesis), it was necessary to use the absorbed guinea pig serum at a much higher concentration (usually 50%) for titrating bactericidal antibody in these specimens. Absorbed guinea pig sera were stored at -20 C.
An 8-hr broth culture diluted to contain 5,000 viable orgaDisms per ml was used as inoculum. Equal volumes (0.5 ml) of this suspension and the antibody sample, which had been serially diluted in peptonesaline (0.1% Difco peptone + 0.85% NaCl), were mixed with an appropriate concentration of guinea pig serum and incubated for 1 hr at 37 C. Tubes containing 0.5 ml of peptone-saline, vibrios, and guinea pig serum served as control of viability. After incubation, 0.04-ml samples of each mixture were plated in quadruplicate. The antibody titer was determined as the reciprocal of the highest dilution of the sample that inhibited the growth of 50% or more of the starting population of bacteria (estimated from growth on viability control plates). Standard high-titer vibrio antiserum was included in each titration as a positive control and also to monitor variation in the performance of the test.
Agglutination test. Tube agglutination was performed with live or heat-killed vibrios which had been washed in saline and resuspended to a turbidity of 228 in a Klett-Summerson colorimeter. Tubes were incubated at 37 C for 45 min and kept overnight at 4 C before being read.
Electrophoresis. Zonal electrophoresis in 0.8% agar was performed at room temperature with 0.05 M veronal buffer, pH 8.6, at a constant current of 80 mA for 90 min. After development of patterns with antisera, slides were stained with 0.1% Azccarmine B (in 2% acetic acid).
Heat-killed vaccines. The streptomycin-resistant strainof V. cholerae (Ogawa) describedearlier (19) was used to prepare the heat-killed vaccine. Confluent overnight growth of the vibrios on veal infusion agar containing 1 mg of streptomycin per ml was washed off with 10 ml of sterile saline per petri dish (100 by 15 mm). The pooled suspension was heated over flowing steam for 2 hr. A fresh suspension of heat-killed vibrios was made for each experiment and stored at 4 C.
Live vaccine. A streptomycin-sensitive strain of V. cholerae (Ogawa) was used for oral immunization of germfree mice. Overnight growth of the organisms on Trypticase soy agar plates was washed off with 10 ml of sterile saline per plate, and the suspension was given to mice in approximately 100 ml of drinking water. Clean water was given to the mice after a 24-hr exposure to the vibrio suspension. Immunization was terminated by the administration of streptomycin (3 mg/ml) in the drinking water for 1 to 5 days. In some experiments tetracycline (10 mg/ml) was also included. Mice were sacrificed 5 days after antibiotic treatment, at which time sera and intestinal washings were taken for titration of antibody.
IgA antibodies. Pregnant rabbits were immunized by the intravenous injection of increasing amounts of heat-killed vibrios at 5-day intervals. After an initial injection of 75 ,ug (dry weight) of vibrios, four more injections were made, containing 150, 300, 600, and 750 ,g, respectively. Starting 24 hr after parturition and for 1 or 2 days thereafter, colostrum was collected with the aid of a small suction pump. The pooled colostrum from each animal was used for the isolation of IgA by the method of Cebra and Robbins (10 5 -day intervals thereafter. Serum for antibody titration was taken at intervals after the second injection, and all mice were bled to death (usually after five injections) when high antibody titers were achieved. The pooled serum was precipitated with 50% saturated ammonium sulfate, concentrated by resuspension in saline to a fraction of the initial volume, and dialyzed against saline. Characteristics of the concentrated material are summarized in Table 7 .
Each mouse recieved 0.2 ml of the pooled concentrated mcuse antiserum into the tail vein. In some experiments, the animals were anesthetized by intraperitoneal injection of pentabarbital. The small intestine was then isolated and ligated into appropriate sections. In instances where washing of the intestine was necessary, this was accomplished by applying a ligature close to the pylorus and flushing the intestine with 20 ml of saline, followed by an equal volume of air. The wash fluid and intestinal contents were allowed to escape through a cut near the cecal end of the small intestine. Ligatures were applied near the cut end, and a few millimeters distal to the puncture wound. Mesentery and blood vessels were left intact throughout the procedure. Intestines were returned to the peritoneal cavity and the incision was closed. The mice then received antiserum intravenously and were sacrificed 2 hr later.
Intraintestinal incubation of antiserum in mice. Sections of the intestine were prepared as described above. An appropriate dilution of the antiserum in a volume not exceeding 1 ml per whole intestine was then injected into the lumen. Puncture wounds were excluded by ligation, the intestine was returned to the peritoneal cavity, and the incision would closed.
Sucrose density gradient ultracentrifugation. Density gradient ultracentrifugation was performed in a Beckman model L3-50 The detection of bactericidal activity in the IgA preparation was unexpected in view of the reported lack of complement-fixing ability in this immunoglobulin class (14, 25, 27, 28, 32, 51 It would appear from these results that intestinal antibody in the rabbit originated from the serum and from local synthesis. Thus, it was impossible to determine the relative contributions of serum-derived or locally synthesized antibodies to the intestine in actively immunized rabbits without resorting to statistical analysis of the data from a relatively large number of animals. Experimentation with moderate size groups (6 to 10 animals) was impossible. Attempts were therefore made to overcome this problem by using mice in subsequent experiments. These animals offered an additional advantage in that germfree mice were available.
Oral
At the intervals studied, antibody was not detected in the intestinal washings until the 15th day of oral immunization, at which time three of five mice responded ( significantly lower than those of orally immunized mice (0.4 to 118%). The difference in ratios is a reflection of the higher serum antibody titers and generally lower intestinal antibody titers in the parenterally immunized as compared with orally immunized animals ( Table 4) .
Characteristics of serum and intestinal antibodies in orally immunized germfree mice. Pooled intestinal washings and sera from 10 orally immunized germfree mice were applied to DEAE columns, and eluates were concentrated by pressure dialysis followed by lyophilization. Antibody content in the DEAE eluates was determined by the Farr test only, since bactericidal antibody was not usually demonstrable in the intestinal washings of these mice. The concentrated fractions were further characterized by immunoelectrophoresis. Finally, the pooled intestinal washings and sera were fractionated by sucrose density gradient ultracentrifugation, and the distribution of antibody in the various regions of the gradient was determined.
Among the eleven peaks obtained by DEAE chromatography of the intestinal washings, antibody activity was demonstrable only in the two fractions eluted when the column buffer was 0.2 M or 0.3 M in NaCl (Table 5 ). These two fractions contained only IgA as determined by immunoelectrophoresis (Fig. 2, slide 1 ). IgG and IgM were present in the unfractionated intestinal washings as determined by immunoelectrophoresis with specific antisera. However, their electrophoretic characteristics were markedly altered. IgG and IgM arcs occurred more anodally than IgG and IgM from the serum (Fig. 2, slides 6 , 9 versus 4, 5, 7). Of the six fractions obtained after DEAE chromatography of the pooled serum from orally immunized germfree mice, antibody was demonstrable in four fractions (Table 5 ). Fractions 1 and 3 contained IgG and IgM, respectively, as shown by immunoelectrophoresis (Fig. 2, slides 3 and 8) . The immunoglobulin class(es) of the material in serum fractions 2 and 4 could not be determined by immunoelectrophoresis, even when several different proportions of these fractions and the anti-immunoglobulin sera were used.
After sucrose density gradient ultracentrifugation of the intestinal washings, the bulk of antibody was demonstrable in the fraction estimated to contain molecules with 9 to 13S sedimentation characteristics (Table 6 ). The largest proportion of antibody activity in the pooled serum was recovered from the sucrose density gradient fraction containing material with 6 to 9S sedimentation velocity. Antibody was also present in the 17 to 20S and <6S fractions ( bSera from each group of mice were pooled for titration. c Intestinal washings from each group of mice were pooled for titration.
on the basis that the total volume of bile in each animal was diluted into 1 ml of intestinal contents). Since the above ratios are within the range often found in intestinal washings of conventional mice, one must conclude that the concentration of serum antibody in bile is sufficiently high to make a substantial contribution to the total intestinal antibody. To determine the site at which serum antibody enters the intestine, in vivo isolated intestinal segments were prepared in conventional mice before intravenous injection of the V. cholerae antiserum. Three segments were prepared in each mouse by ligatures at approximately 10-cm intervals from pylorus to cecum, the first ligature being made approximately 10 cm distal to the pylorus. Mice were sacrificed 2 hr after passive immunization, at which time washings from the intestinal segments were processed as in the previous experiments.
The results (Table 11) showed that a greater proportion of antibody was detected in the second and third segments than in the first segment in two of three mice. These results suggest (i) that bile makes no predominant contribution to antibody in the intestine, or (ii) that antibody may be degraded at a faster rate in the first segment than in the others.
The absence of detectable antibody in the intestines of passively immunized germfree mice (Table 10 ) and its presence in conventionalized (or conventional) mice (Tables 8, 10 , and 11) may be explained by at least two hypotheses. First, there may be no passage of antibody from the circulation into the intestine in germfree mice. Alternatively, passage of antibody into the intestine may be comparable in the two types of mice but with accelerated loss in the germfree intestine. These hypotheses were tested in the subsequent series of experiments.
Intraintestinal incubation of antibody. The intestine of germfree or conventional mice was ligated at the pylorus and a few millimeters from the cecum. After the injection of 1 ml of diluted mouse V. cholerae antiserum into the closed intestine, the puncture wound was isolated by ligature, and the intestine was returned into the peritoneal cavity. Mice were sacrificed 1 hr later, at which time intestinal washings were prepared and titrated for antibody (Table 12, I and III) . It is evident from the results that considerably less antibody is recovered in the germfree than in the conventional mouse intestinal segments. No bactericidal antibody was recovered.
To determine whether there was a difference in the stability of antibody at various levels of the small intestine, segments were prepared in germfree mice by ligation in the anterior, middle, and posterior thirds of the small intestine, and 0.3 ml of diluted mouse V. cholerae antiserum was injected into each isolated intestinal segment. Mice were sacrificed 1 hr later, and the amount of antibody present in each segment was determined. No consistent pattern of antibody recovery was evident (Table 13 ). However, in three of four mice studied, a smaller fraction of antibody was recovered in the anterior than in the middle or posterior segments of the intestine. Again no bactericidal antibody was recovered.
Appearance of antibody from circulation in washed intestines. Before the degree of passage of antibody from the circulation into the intestine was estimated, conditions were sought where the intestinal degradation of antibody would be minimal. Intestines of germfree and conventional mice were flushed out with 20 ml of saline, 
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followed by an equal volume of air, before in vivo isolated intestinal segments were prepared. Isolated segments were made by ligatures at the pylorus and a few millimeters from the cecum. In some instances, additional ligatures were made to obtain more than one segment per intestine. The antibody titer of diluted mouse V. cholerae antiserum injected into these segments (1 ml per intestine) was estimated after a 1-hr incubation in vivo (Table 12 , II and IV).
The recovery of injected antibody was markedly improved in germfree mice as compared with the recovery in unwashed intestines. It should be noted that this is the only instance where bactericidal antibody was recovered from the intestine of germfree mice. Since IgM antibody is detected at higher titers by the bactericidal test as compared with the Farr test (Tables 1 and 7) , one must conclude that no IgM antibody had remained in the intestine of untreated animals (in contrast to animals with washed intestines). Since the antiserum used contained IgG and IgM antibodies (Table 7) , it appears that IgM antibody was by far the least stable in the intestinal lumen.
The finding that serum antibodies remained reasonably stable in washed, isolated intestinal segments made it possible to test directly for diffusion of serum antibody into the lumen of the intestine of germfree and conventional mice. a Antiserum was injected into isolated intestinal segments prepared by application of ligatures at the pylorus and a few millimeters from the cecum.
b Each intestine was flushed out with 20 ml of saline followed by an equal volume of air before the intestine was ligated and treated as described in footnote a.
Washed, isolated intestinal segments (one or two per animal) were prepared in germfree and conventional mice prior to the intravenous injection of V. cholerae antiserum. Mice were sacrificed 2 hr after injection of antiserum, at which time washings from intestinal segments and serum were prepared and titrated for antibody.
The ratios of intestinal to serum antibody titers in conventional mice were 0.3% or 0.5% to 1.5% in the Farr or bactericidal tests, respectively (Table 14) . Only slightly lower ratios were obtained in the germfree mice (0-0.6% Farr, and 0-0.3% bactericidal). Assuming that as much as 46% of antibody (determined in the Farr test) may be degraded in the washed germfree intestine (Table 12) , the antibody detected in the washed intestine after intravenous injection of antiserum probably represents approximately half of the actual amount of antibody entering the intestine. Thus, a closer approximation of the maximal ratio of intestinal to serum antibody titers in germfree mice would be 1.2% (Farr) and 0.6% (bactericidal). Similar calculations for conventional mice result in ratios of 0.4% (Farr) and 1.9% (bactericidal). The ratios are thus generally comparable for germfree and conventional mice.
In vitro effect of intestinal washings on mouse serum antibody. The results reported above indicated that antibody was less stable in the germfree than in the conventional mouse intestine. To account for this difference, washings were taken from untreated germfree or conventional mouse intestines and incubated at 37 C for 1 hr with mouse V. cholerae antiserum. Antibody titers were determined before and after incubation with washings (Table 15) . A higher propor-V/OL. 6, 1972 35 origin of such antibody. "Locally produced antibody" refers to antibody synthesized in intestinal re prepared tissues. This is contrasted with "systemic" or at approxi-"serum antibody" which is synthesized elsewhere -terminating in the body, accumulates in the blood, and may ately 10 cm or may not reach the mucosal surface and inat the end of testinal lumen to become coproantibody.
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The present study is a consequence of earlier :overed from attempts to simulate in animals the conditions in the above obtaining in man after oral or parenteral vaccinaricidal anti-tion. As has been demonstrated earlier (9, 18) , coproantibody titers in human volunteers dis- (Tables 8, 9, 11) indicates that the same conclusion may be drawn for these animals. In contrast, there was a sharp separation between serum and coproantibody in germfree mice. The present data indicate that this separation was not due to an inability of serum antibody to reach the intestinal lumen. Rather, serum antibodies (mostly IgG and IgM) appeared to reach the intestinal lumen of germfree mice as readily as in conventional animals ( Table 14) . The difference was due to the rapid destruction of serum IgG and IgM in the lumen of the germfree mouse intestine, presumably due to the presence of high concentrations of proteolytic enzymes (Tables 12, 13, 15 ). Increased concentrations of intestinal enzymes in germfree animals have been reported by others (30, 35, 36, 48, 55) . Coproantibodies could only be detected in actively vaccinated germfree mice (Table  4) , and never after passive imunization. These coproantibodies were exclusively in the secretory IgA fraction (Tables 5, 6 ) and apparently were locally produced because they were not detectable in the serum. One must conclude, then, that only locally produced IgA antibodies of the secretory (llS) variety which are known to be highly resistant to proteolytic digestion (6, 11, 15, 45, 52 ; A. Plaut, J. Bienenstock, and T. B. Tomasi, Jr., quoted in reference 51) were present in detectable quantities in the germfree mice.
The data presently available suggest that, of the animals tested, only germfree mice resembled man with respect to the distinct behavior of serum and coproantibody titers and that conventional rabbits or mice reacted quite differently. It remains to be seen whether the distinct behavior of these two fractions observed in man is a consistent phenomenon and whether it is based on similar mechanisms as demonstrated in the germfree mouse. One should note, however, that coproantibody of serum origin is known to be rather unstable in the intestine of man (18) .
As mentioned in the introduction to this paper, the question of whether or not antibacterial or antitoxic immunity to experimental cholera involves local immunity is still not settled. Much of the evidence pertaining to this problem is based on experiments testing protection against experimental cholera in animals passively immunized by the intravenous route (12, 24, 39, 47) . As detailed in the introduction, the finding of protection under such circumstances may be interpreted as evidence for a systemic immune mechanism. However, as the present paper demonstrates, such data may merely indicate that, in the particular animals used, systemic antibody accumulated in the intestine in sufficient amounts to function as coproantibody. It is noteworthy that most of these experiments were done in rabbits (24, 39, 47) , a species in which the permeability of the intestine to serum antibodies has been demonstrated by earlier workers (2, 23, 38, 53) The present paper describes a new mechanism by which intestinal flora contribute to host resistance to enteric infections: the sparing of coproantibody, especially that of serum origin.
The data in Table 10 suggest that this is not an all-or-none effect, but that the quality of the flora (as distinguished in Table 10 by its effect on cecal size) is important as well. This lends weight to the assumption that, as the intestinal flora change in a given individual (due to changes in environment, diet, fasting, etc.), this will be followed by changes in the contribution made by his serum antibody to local immunity in the intestine. Obviously, any other factor which changes the level of intestinal proteolytic enzymes will have the same effect. One may therefore suspect that, whatever contribution serum antibody may make to local intestinal immunity in man, this effect is likely to be highly variable between individuals and even within a given individual at different times.
